Arca
Skip to content
Tools
Tools

BMPR1B: Bone morphogenetic protein receptor type-1B

On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases.

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on BMPR1B, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 2

Approved2

  • Dibotermin alfa
  • Eptotermin alfa

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        Dibotermin alfaApprovedLocate Bio LtdProtein or peptideAgonistBone morphogenetic protein receptor type-1B agonist8
        Eptotermin alfaApprovedStrykerProtein or peptideAgonistBone morphogenetic protein receptor type-1B agonist0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        A Study of LDGraft In Single Level Lumbar Interbody FusionDibotermin alfaPhase 1 / Phase 2RecruitingLocate Bio LtdOct 5, 2026
        Standard- and Micro-Dose rhBMP-2 for Implant Stability, Marginal Bone Loss, and Postoperative Sequelae: A Double-Blind Randomized Controlled TrialDibotermin alfaNot applicableNot yet recruitingUniversity of BaghdadJul 10, 2026
        Clinical Study of BMP-2 Injectable Hydrogel for Promoting Alveolar Bone RegenerationDibotermin alfaNot applicableNot yet recruitingThe First Affiliated Hospital of Xinxiang Medical CollegeMay 28, 2026
        Effect of Mandibular Drilling Speed on Implant Stability and Osteogenic Potential: A Randomized Clinical TrialDibotermin alfaNot applicableNot yet recruitingCairo UniversityMar 16, 2026
        LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)Dibotermin alfaPhase 1 / Phase 2RecruitingLocate Bio Pty LtdJun 17, 2024
        Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen®Dibotermin alfaNot applicableRecruitingLindenhofgruppe AGFeb 14, 2022
        Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and PalateDibotermin alfaPhase 4RecruitingThe University of Texas Health Science Center, HoustonJan 21, 2020
        Transforaminal Lumbar Interbody Fusion (TLIF)Dibotermin alfaNot applicableActive, not recruitingMedtronic Spinal and BiologicsAug 29, 2019

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        • Brachydactyly type A20.76
        • Acromesomelic dysplasia 30.74
        • Brachydactyly type A10.63
        • Diverticular disease0.51
        • Bone disorder0.46
        • Tibia fracture0.46
        • Acromesomelic dysplasia 2B0.46
        • Menorrhagia0.46
        • Coronary artery disorder0.43
        • Brachydactyly0.43
        • Hypertensive disorder0.41
        • Acromesomelic dysplasia 2A0.39

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL5476, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt O00238, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.